University of Minnesota. Driven to Discover.
Funding will be used to continue trials of BCX4430 and prepare for its large-scale manufacture.
The first batch of an experimental Ebola vaccine landed today in an outbreak country, with officials projecting a trial launch in Liberia within weeks.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.